Ahmed S. et. al.( 1997) Efficacy of Risperidone in first-episode psychosis. Poster presentation. 6^th International Congress of Schizophrenia Research, Colorado Springs, Colo­rado, USA.

American Psychiatric Association. (1997) Practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry 154 (4 Suppl): 1-63.

Bebbington P. (2000) Early intervention in psychosis: pharmacotheropeutic strategies. In M. Birchwood, C. Jackson and D. Fowler (Eds.) Early Intervention in Psychosis Wiley: Chichester.

Bech P., et. al. (1998) Meta-analytic study of the benefits and risks of treating chronic schizophrenia with Risperidone or conventional neuroleptics. European Psychiatry 13:310-314.

Bethlem and Maudsley NHS Trust. (1999) Prescribing Guidelines. Dunitz: London.

Cole J.O. et. al. (1964) Phenothiazine treatment in acute schizophrenia. Archives of General Psychiatry; 10; 246-261.

Crow T.J. et. al. (1986) The Northwick Park study of first episode schizophrenia: II. A randomized controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry 148: 120-127.

Edwards J. et. al. (1998) Prolonged recovery in first-episode psychosis. British Journal of Psychiatry; 172 (Suppl. 33): 107-116.

Emsley R.A. (1999) Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Schizophrenia Bulletin 1999; 25: 721-729.

Expert Consensus Panel. Treatment of schizophrenia: the expert consensus guideline series. Journal of Clinical Psychiatry; 60 (Suppl 11): 3-80.

Kapur S. et. al. (1996). High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: al PET study. American Journal of Psychiatry 153: 948-950.

Kennedy E. et. al. (2000). Risperidone versus typical antipsychotic medication for schizophrenia (Cochrane Review). In: the Cochrone Library Issue 1, Oxford: Update Soft­ware.

Kissing W. (Ed.). York, NY: Springer-Verlag. Guidelines for Neuroleptic Relapse Prevention in Schizophrenia.

Kopala L.C. (1997). Clinical experience in developing treatment regimens with the novel antipsychotic risperidone. International Clinical Psychopharmacology; 1 2(suppl 4): S11 -S18.

Kopala L.C. et. al. (1997). Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low dose risperidone. Journal of Clinical Psychopharmacology 17: 308-313.

Koreen A.R. et. al. (1993). Depression in first-episode schizophrenia. American Journal of Psychiatry 11: 1643-1648.

Lieberman J. et. al. (1993). Time course and biologic correlates of treatment response in first-episode schizophrenia. Archives of General Psychiatry 50: 369-376.

McEvoy J. et. al. (1991). Optimal dose of neuroleptic in acute schizophrenia: A Controlled study of the neuroleptic threshold and higher haloperidol dose. Archives of General Psychiatry; 488: 739-745.

McGorry P.D. (1999). Recommended haloperidol and risperidone doses in first-episode psychosis (Letter). Journal of Cllnical Psychiatry 60: 794.

The National Early Psychosis Project (NEPP). (1998). Australian Guidelines for Early Psychosis. University of Melbourne: Melbourne.

Remington G., Chong SR. (1999). Conventional versus novel antipsychotics: changing concepts and clinical implications. Journal of Psychiatry and Neuroscience 24: 431-441.

Remington G. et. al. (1998). Pharmacotherapy of first-episode schizophrenia. British Journal of Psychiatry 172 (suppl. 33): 66-70.

Robinson D. et. al. (1996). Pilot study of atypical antipsychotic agents in first episode schizophrenia. Presented at 35^th Annual Meeting of the American College of Neuropsycholpharmacology, San Juan, Puerto Rico.

Robinson D. et. al. (1999). Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 56: 241-246.

Sanger TM. et. al. (1999). Olanzapine versus haloperidol treatment in first-episode psychosis. American Journal of Psychiatry 156: 79-87.

Szymonski S.R. et. al. (1996). Course of treatment response in first-episode and chronic schizophrenia. American Journal of Psychiatry; 153: 519-525.

Tohen M. et. al. (1992). The McLean First-Episode Psychosis Project: Six-month recovery and recurrence outcome. Schizophrenia Bulletin; 18: 272-282.

Wong J. et. al. (1996). Optimal haloperidol dosage for first episode schizophrenia. Biological Psychiatry; 39: 519.

Working Group for the Canadian Psychiatric Association and the Canadian Alliance for Research on Schizophrenia (1998). Canadian Clinical Practice Guidelines for the Treatment of Schizophrenia. The Canadian Journal of Psychiatry; 43 (Suppl 2).

Zipursky. A (2000). Optimal treatment of first episode schizophrenia over the first five years. Paper presented at the 2^nd International Conference on Early Psychosis. New York City.